Autism spectrum disorders (ASDs) are an early onset, heterogeneous group of heritable neuropsychiatric disorders with symptoms that include deficits in social interaction skills, impaired communication abilities, and ritualistic-like repetitive behaviours 1,2 . One of the hypotheses for a common molecular mechanism underlying ASDs is altered translational control resulting in exaggerated protein synthesis 3 . Genetic variants in chromosome 4q, which contains the EIF4E locus, have been described in patients with autism 4,5 . Importantly, a rare single nucleotide polymorphism has been identified in autism that is associated with increased promoter activity in the EIF4E gene 6 . Here we show that genetically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice 7 results in exaggerated cap-dependent translation and aberrant behaviours reminiscent of autism, including repetitive and perseverative behaviours and social interaction deficits. Moreover, these autistic-like behaviours are accompanied by synaptic pathophysiology in the medial prefrontal cortex, striatum and hippocampus. The autistic-like behaviours displayed by the eIF4E-transgenic mice are corrected by intracerebroventricular infusions of the capdependent translation inhibitor 4EGI-1. Our findings demonstrate a causal relationship between exaggerated cap-dependent translation, synaptic dysfunction and aberrant behaviours associated with autism. eIF4E-transgenic mice (bT-Eif4e) 7 exhibited increased levels of eIF4E across brain regions ( Fig. 1a ) without compensatory changes in levels of other translational control proteins ( Fig. 1b ). We investigated whether eIF4E was bound preferentially to either eIF4E-binding protein (4E-BP) or eIF4G, which repress and promote, respectively, the initiation of cap-dependent translation 8,9 . We found significantly higher levels of eIF4E-eIF4G interactions in the brains of eIF4Etransgenic mice ( Fig. 1c and Supplementary Fig. 1a ), with no alterations in the interaction between eIF4E and 4E-BP ( Fig. 1c , left, and Supplementary Fig. 1a ). To confirm that the increased eIF4E-eIF4G interactions resulted in increased protein synthesis, we infused puromycin into the lateral ventricle of cannulated mice and labelled newly synthesized proteins using SUnSET 10,11 , and observed increased de novo cap-dependent translation ( Fig. 1d and Supplementary  Fig. 1b-g) . Overall, our results indicate that overexpression of eIF4E results in exaggerated cap-dependent translation in the brains of eIF4E-transgenic mice.
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We then determined whether eIF4E-transgenic mice display repetitive and perseverative behaviours, which are behavioural domains required for ASD diagnosis 2 . eIF4E-transgenic mice exhibited repetitive digging behaviour in the marble-burying test 12 and increased selfgrooming 13 compared with wild-type littermate controls ( Fig. 2a, b ). eIF4E-transgenic mice also displayed cognitive inflexibility in both a water-based Y-maze task and a modified version of the Morris water maze 14, 15 . Learning ability in the acquisition and memory phases of these tasks was intact; however, in the reversal phases, eIF4E-transgenic mice were impaired in locating the new platform positions (Fig. 2c, d and Supplementary Fig. 2e -h). We tested an additional form of behavioural inflexibility by examining the eIF4E-transgenic mice for extinction of cued fear conditioning and found that they did not exhibit a significant reduction in freezing responses after extinction training ( Fig. 2e) . These experiments suggest that excessive cap-dependent translation in the brain affects the ability to suppress previously codified response patterns and the ability to form new behavioural strategies in response to changed environmental circumstances.
Abnormalities in social interaction skills are another behavioural defect displayed by individuals with ASDs 2 . In tests to examine social behaviour [16] [17] [18] , the eIF4E-transgenic mice did not show a preference for a nonspecific stranger versus a new, inanimate object ( Fig. 2f, g) . Moreover, eIF4E-transgenic mice exhibited diminished reciprocal interactions with a freely moving stranger mouse ( Fig. 2h ), further evidence of deficits in social behaviour. The deficits in social behaviour of the eIF4E-transgenic mice are unlikely to be caused by a generalized increase in anxiety ( Supplementary Fig. 2c , d, j). Moreover, the eIF4Etransgenic mice exhibited mild hyperactivity ( Supplementary Fig. 2a, b ), but no impairments in motor coordination, motor learning and sensorimotor gating ( Supplementary Fig. 2i , k, l). Taken together, our behavioural analysis of the eIF4E-transgenic mice indicates that increased cap-dependent translation in the brain results in a distinct pattern of behavioural abnormalities consistent with ASDs.
Previous studies suggest that ASD symptoms such as cognitive inflexibility and deficits in social behaviour are generated by abnormalities in prefrontal and/or striatal circuits 19 . Consistent with this idea, the medial prefrontal cortex (PFC) is implicated in the modulation of social behaviours and social skills 20 , whereas motor, social and communication impairments in boys with ASDs are associated with anatomical abnormalities in the striatum 21 . Therefore, we next examined whether the eIF4E-transgenic mice exhibited specific synaptic pathophysiologies in the medial PFC and striatum.
In the eIF4E-transgenic mice, examination of spontaneous synaptic 'mini' events in layers 2/3 of acute medial PFC slices revealed an increase in the frequency but not amplitude of excitatory events (miniature excitatory postsynaptic currents (mEPSCs); Fig. 3a ), and an increase in the amplitude, but not frequency, of inhibitory events (miniature inhibitory postsynaptic currents (mIPSCs); Fig. 3b ). No changes were observed in layer 5 ( Supplementary Fig. 3a, b ). Thus, our data suggest an enhancement of excitatory input and postsynaptic sensitivity for inhibitory events onto layer 2/3 pyramidal neurons, consistent with the hypothesis that autism may arise from an imbalance between excitatory and inhibitory synaptic transmission 22 .
To determine whether the increased frequency of spontaneous mEPSCs might result from an enhanced number of synaptic contacts, we imaged dendritic spines using two-photon laser-scanning microscopy (Fig. 3c, d and Supplementary Fig. 3c, d ). We found a significant increase (,12%) in spine density and observed a significantly smaller spine volume in the eIF4E-transgenic mice than in wildtype littermates (wild type 5 0.123 6 0.004 mm 3 (mean 6 s.e.m.) and eIF4E-transgenic 5 0.110 6 0.004 mm 3 , P 5 0.01 versus wild type, Student's t-test).
Next, we examined whether increased expression of eIF4E also resulted in synaptic pathophysiology in the striatum. We used high-frequency stimulation to induce long-term depression (LTD) in acute striatal slices 23 , and found that eIF4E-transgenic mice exhibited enhanced LTD compared to wild-type littermates ( Fig. 3e and Supplementary Fig. 3e , f ). We propose that the enhanced LTD in eIF4E-transgenic mice results in altered efficiency of striatal information storage and processing, culminating in the inability to form new motor patterns and/or to disengage from previously learned motor behaviours. 
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To determine whether the synaptic alterations described in the eIF4E-transgenic mice were selective for the frontostriatal circuit, we examined synaptic plasticity in the hippocampus 24 . We found that eIF4E-transgenic mice exhibited enhanced metabotropic glutamate receptor-dependent LTD (mGluR-LTD) compared to wild-type littermates ( Fig. 3f and Supplementary Fig. 3g, h) , consistent with previous studies showing that changes in brain protein synthesis are accompanied by altered (enhanced or reduced) hippocampal mGluR-LTD 25, 26 . Thus, consistent with the ubiquitous increase in brain expression of eIF4E, the eIF4E-transgenic mice display altered synaptic function and plasticity in several brain regions (medial PFC, striatum and hippocampus) implicated in behavioural abnormalities associated with ASDs. 
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Finally, we asked whether exaggerated cap-dependent translation was responsible for the synaptic alterations and ASD-like behaviours shown by the eIF4E-transgenic mice. We took advantage of 4EGI-1, an inhibitor of eIF4E-eIF4G interactions 8, 11 , to block the synaptic and behavioural consequences of increased eIF4E expression. Bath application of 4EGI-1 normalized the enhanced striatal LTD observed in the eIF4E-transgenic mice (Fig. 3g, h ), suggesting that exaggerated striatal LTD (Fig. 3h) is a direct consequence of increased binding of eIF4E to eIF4G ( Supplementary Fig. 3i-k) .
Next, we used a subthreshold dose of 4EGI-1 (ref. 11) to normalize the behavioural abnormalities in eIF4E-transgenic mice without impairing their wild-type littermates. eIF4E-transgenic mice treated with 4EGI-1 exhibited a decrease in repetitive behaviour during the marble-burying task, which started on day four and persisted throughout day five (Fig. 4a ). Moreover, we found that 4EGI-1 maintained the behavioural effects observed in the marble-burying task (Supplementary Fig. 4a, b ). We also found that blockade of eIF4E-eIF4G interactions with 4EGI-1 significantly improved the performance of eIF4E-transgenic mice in the reversal phase of the Y-maze test (Fig. 4b) . These findings indicate that chronic treatment of eIF4Etransgenic mice with 4EGI-1 reverses their repetitive and perseverative behaviours. We also found that infusions of 4EGI-1 rescued the social behaviour deficits shown by the eIF4E-transgenic mice in the threechamber arena test, as they exhibited an increased preference for a nonspecific stranger compared to a new object ( Fig. 4c) .
At the completion of the behavioural studies with 4EGI-1, we performed co-immunoprecipitation experiments, confirming that 4EGI-1 reduced the increased eIF4E-eIF4G interactions exhibited by the eIF4E-transgenic mice ( Fig. 4d and Supplementary Fig. 4c-e ). Furthermore, puromycin-labelling of newly synthesized proteins was reduced to wild-type levels, indicating that 4EGI-1 was effective in attenuating the increased cap-dependent translation in the eIF4Etransgenic mice ( Fig. 4e and Supplementary Fig. 4f, g) . Together, these results indicate that repeated treatment of eIF4E-transgenic mice with 4EGI-1 reverses the increased binding of eIF4E to eIF4G, exaggerated cap-dependent translation, and reversal of ASD-like behaviours.
Here we have demonstrated that increased eIF4E expression and, consequently, dysregulated translational control at the initiation phase of protein synthesis in mice results in the appearance of synaptic dysfunction and aberrant behaviours consistent with ASDs. On the basis of our observations, we propose that exaggerated cap-dependent protein synthesis in the eIF4E-transgenic mice and fragile X syndrome model mice 27, 28 results in enhanced translation of a specific subset of messenger RNAs. Thus, the identity of both these mRNAs and the cis-acting elements in the 59 untranslated region responsible for eIF4E-dependent protein synthesis and their possible overlap with fragile X mental retardation protein target mRNAs will be important investigations in future studies.
Our studies with eIF4E-transgenic mice indicate that ASD-like behaviours can be induced by exaggerated cap-dependent translation in the brain. Moreover, we demonstrated that aberrant repetitive, perseverative and social behaviours shown by eIF4E-transgenic mice are reversed by reducing eIF4E-eIF4G interactions, thereby restoring translational homeostasis. Thus, our findings establish a causal link between exaggerated cap-dependent translation and behaviours associated with autism. Finally, our findings indicate that behavioural defects caused by exaggerated cap-dependent translation, which also occurs in fragile X syndrome 29, 30 , a disorder with a high incidence of autism, are not irrevocable and can be corrected well into adulthood.
METHODS SUMMARY
All procedures involving animals were approved by the New York University Animal Care and Use Committee and followed the National Institutes of Health Guidelines for the use of animals in research. For a detailed description of all the techniques used in this study, please see the Methods. All the experiments were performed with the examiners blinded to genotype. Figure 4 | The cap-dependent translation inhibitor 4EGI-1 reverses ASDlike behaviours shown by eIF4E-transgenic mice. a, Treatment of eIF4Etransgenic mice with 4EGI-1 reduces the marble-burying behaviour. n 5 6 mice per genotype and treatment; *P , 0.05, **P , 0.01, two-way repeated-measures ANOVA (treatment 3 genotype, F (1,20) 5 4.21, P , 0.05) followed by Bonferroni-Dunn post-hoc test. b, 4EGI-1 improves the cognitive flexibility of eIF4E-transgenic mice in the Y-maze test. n 5 6-7 mice per genotype and treatment; *P , 0.05, **P , 0.01, two-way repeated-measures ANOVA (treatment 3 genotype, F (1,21) 5 4.61, P , 0.05) followed by Bonferroni-Dunn post-hoc test. c, 4EGI-1 improves social behaviour of eIF4E-transgenic mice in the three-chamber arena test. n 5 6 mice per genotype and treatment; *P , 0.05, two-way repeated-measures ANOVA (treatment 3 genotype, F (1,20) 5 6.26, P , 0.05) followed by Bonferroni-Dunn post-hoc test. d, 4EGI-1 decreases the enhanced eIF4E-eIF4G interactions in eIF4E-transgenic mice. Immunoprecipitation of eIF4E in the striatum. n 5 4 mice per genotype; *P , 0.05 (versus vehicle-treated wild type), {P , 0.05 (versus 4EGI-1-treated wild type), two-way ANOVA, followed by Bonferroni-Dunn post-hoc test. e, 4EGI-1 normalizes the exaggerated cap-dependent translation in eIF4Etransgenic mice as measured with SUnSET. The last wild-type sample represents a control without puromycin. *P , 0.05, {P , 0.05, two-way ANOVA followed by Bonferroni-Dunn post-hoc test. All data are shown as mean and s.e.m.
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